205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.88%
Revenue decline while MCHP shows 7.38% growth. Joel Greenblatt would examine competitive position erosion.
-2.50%
Cost reduction while MCHP shows 6.79% growth. Joel Greenblatt would examine competitive advantage.
-3.46%
Gross profit decline while MCHP shows 7.97% growth. Joel Greenblatt would examine competitive position.
-0.60%
Margin decline while MCHP shows 0.55% expansion. Joel Greenblatt would examine competitive position.
169.45%
R&D growth above 1.5x MCHP's 7.57%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
83.97%
Operating expenses growth above 1.5x MCHP's 9.05%. Michael Burry would check for inefficiency.
22.69%
Total costs growth above 1.5x MCHP's 7.57%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-96.97%
D&A reduction while MCHP shows 2.78% growth. Joel Greenblatt would examine efficiency.
-181.54%
EBITDA decline while MCHP shows 5.49% growth. Joel Greenblatt would examine position.
-183.96%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-155.87%
Operating income decline while MCHP shows 6.80% growth. Joel Greenblatt would examine position.
-157.52%
Both companies show margin pressure. Martin Whitman would check industry conditions.
340.00%
Other expenses growth above 1.5x MCHP's 89.33%. Michael Burry would check for concerning trends.
-142.39%
Pre-tax income decline while MCHP shows 9.56% growth. Joel Greenblatt would examine position.
-143.65%
Pre-tax margin decline while MCHP shows 2.03% growth. Joel Greenblatt would examine position.
-17.05%
Tax expense reduction while MCHP shows 2.24% growth. Joel Greenblatt would examine advantage.
-116.65%
Net income decline while MCHP shows 12.27% growth. Joel Greenblatt would examine position.
-117.14%
Net margin decline while MCHP shows 4.55% growth. Joel Greenblatt would examine position.
-116.07%
EPS decline while MCHP shows 9.00% growth. Joel Greenblatt would examine position.
-116.82%
Diluted EPS decline while MCHP shows 9.00% growth. Joel Greenblatt would examine position.
0.87%
Share count reduction exceeding 1.5x MCHP's 3.37%. David Dodd would verify capital allocation.
-0.32%
Diluted share reduction while MCHP shows 3.37% change. Joel Greenblatt would examine strategy.